Editas Medicine logo

Editas Medicine

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

5

Funding Rounds

$656.6m

Money raised

Overview

Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases.

Industries

Editas Medicine is active in the following industries:
  • Pharmaceutical industry
  • Therapeutics
  • Genetic engineering
  • Healthcare
  • Biomedical engineering
  • Genomics
  • Technology
  • RNA-based and RNA-targeted therapeutics
  • Synthetic biology
  • Biology
  • Biotechnology
  • Genome editing
  • Regenerative medicine
  • Tissue engineering
  • Engineering
  • Synthetic chemistry
  • Induced pluripotent stem cell